Combination therapy of renal cell carcinoma or breast cancer patients with dendritic cell vaccine and IL-2: results from a phase I/II trial

Combination therapy of renal cell carcinoma or breast cancer patients with dendritic cell vaccine and IL-2: results from a phase I/II trial

<p>Abstract</p> <p>Background</p> <p>Ten cancer patients (Six renal cell carcinoma and four breast cancer patients) were treated in a phase I/II study with a vaccine composed of autologous dendritic cells (DCs) and IL-2 to evaluate the DC vaccine-related toxicity and an...

Full description

Bibliographic Details
Main Authors: Kim YongMan, Kwon Seog-Woon, Kim Yong-man, Kim Sung-Bae, Kim Choung-Soo, Baek Soyoung, Kim HyunSoo, Lee Hyunah
Format: Article
Language:English
Published: BMC 2011-10-01
Series:Journal of Translational Medicine
Subjects:
Dendritic cell vaccine
Renal cell carcinoma
Breast cancer
Phase I/II trial
Immune response
Online Access:http://www.translational-medicine.com/content/9/1/178

Internet

http://www.translational-medicine.com/content/9/1/178

Similar Items